Plk1 inhibitors in cancer therapy: from laboratory to clinics

REA Gutteridge, MA Ndiaye, X Liu… - Molecular cancer …, 2016 - aacrjournals.org
Abstract Polo-like kinase 1 (Plk1) overexpression has been shown to occur in a wide range
of tumors, prompting research and development of Plk1 inhibitors as a means of cancer …

[HTML][HTML] Targeting polo-like kinases: a promising therapeutic approach for cancer treatment

X Liu - Translational oncology, 2015 - Elsevier
Polo-like kinases (Plks) are a family of serine-threonine kinases that regulate multiple
intracellular processes including DNA replication, mitosis, and stress response. Plk1, the …

[HTML][HTML] Phosphorylation of Nup98 by multiple kinases is crucial for NPC disassembly during mitotic entry

E Laurell, K Beck, K Krupina, G Theerthagiri… - Cell, 2011 - cell.com
Disassembly of nuclear pore complexes (NPCs) is a decisive event during mitotic entry in
cells undergoing open mitosis, yet the molecular mechanisms underlying NPC disassembly …

A Nup133-dependent NPC-anchored network tethers centrosomes to the nuclear envelope in prophase

S Bolhy, I Bouhlel, E Dultz, T Nayak, M Zuccolo… - Journal of Cell …, 2011 - rupress.org
Centrosomes are closely associated with the nuclear envelope (NE) throughout the cell
cycle and this association is maintained in prophase when they separate to establish the …

Non-mitotic functions of polo-like kinases in cancer cells

CA Raab, M Raab, S Becker, K Strebhardt - Biochimica et Biophysica Acta …, 2021 - Elsevier
Inhibitors of mitotic protein kinases are currently being developed as non-neurotoxic
alternatives of microtubule-targeting agents (taxanes, vinca alkaloids) which provide a …

PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus–Induced Liver Carcinogenesis

H Zhang, A Diab, H Fan, SKK Mani, R Hullinger… - Cancer …, 2015 - aacrjournals.org
Elucidating mechanisms of hepatitis B virus (HBV)–mediated hepatocarcinogenesis is
needed to gain insights into the etiology and treatment of liver cancer. Cells where HBV is …

Mitotic disassembly of nuclear pore complexes involves CDK1-and PLK1-mediated phosphorylation of key interconnecting nucleoporins

MI Linder, M Köhler, P Boersema, M Weberruss… - Developmental Cell, 2017 - cell.com
During interphase, the nuclear envelope (NE) serves as a selective barrier between cytosol
and nucleoplasm. When vertebrate cells enter mitosis, the NE is dismantled in the process of …

Inhibitors of the PLK1 polo-box domain: drug design strategies and therapeutic opportunities in cancer

JM Stafford, MD Wyatt, C McInnes - Expert Opinion on Drug …, 2023 - Taylor & Francis
ABSTRACT Introduction Polo Like Kinase 1 (PLK1) is a key regulator of mitosis and its
overexpression is frequently observed in a wide variety of human cancers, while often being …

Molecular dynamics of PLK1 during mitosis

S Schmucker, I Sumara - Molecular & cellular oncology, 2014 - Taylor & Francis
Polo-like kinase 1 (PLK1) is a key regulator of eukaryotic cell division. During mitosis,
dynamic regulation of PLK1 is crucial for its roles in centrosome maturation, spindle …

Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer

Z Zhang, X Hou, C Shao, J Li, JX Cheng, S Kuang… - Cancer …, 2014 - aacrjournals.org
Prostate cancer is thought to be driven by oxidative stress, lipid metabolism, androgen
receptor (AR) signaling, and activation of the PI3K–AKT–mTOR pathway, but it is uncertain …